A University of Colorado Cancer Center review published in the journal Brain Research provides an overview of TAM family cell signaling in the central nervous system, and specifically within the cancer gioblastoma multiforme.
Researchers detail possible resistance mechanisms of colorectal cancer to bevacizumab (Avastin)
October 28, 2013 · Comments Off
A University of Colorado Cancer Center study published in the journal PLoS One shows that, like overflowing a dam, colorectal cancer may resist the drug bevacizumab (Avastin), by switching dependence from the main flow of VEGF-A to the "tributaries" of related growth factors including VEGF-C, VEGF-D and placental growth factor.
New genetic error in some lung cancers identified by CU scientists
October 28, 2013 · Comments Off
A study lead by scientists at University of Colorado Cancer Center and Dana-Farber Cancer Institute in Boston has uncovered a new sub-type of lung cancer. The study revealed a gene fusion -- a forced merger of two normally separate genes – that spurs the cells to divide rapidly causing non-small cell lung cancer. The study is published in the journal Nature Medicine.
Study: Metformin for Breast Cancer Less Effective at Higher Glucose Concentrations
October 23, 2013 · Comments Off
A University of Colorado Cancer Center study published online this month in the journal Cell...
New Cell Sorter Speeds Research at University of Colorado Cancer Center
October 16, 2013 · Comments Off
Purchased with $400k from the Dean's Academic Enrichment Fund, and additional monies from the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology and the CU Cancer Center, the new MoFlo Astrios EQ cell sorter allows more sensitive, faster sorting.
Childhood melanoma could be on the rise in Colorado
October 8, 2013 · Comments Off
An article from HealthDay boosts the skin cancer research of CU Cancer Center investigator and assistant...
$5.9M Grant Adds Androgen Receptor as a New Driver and Target in Breast Cancer
October 1, 2013 · Comments Off
A major Department of Defense grant to researchers Jennifer Richer, PhD, and Anthony Elias, MD, at the University of Colorado Cancer Center aids development of drugs that target androgen receptors as a driver of breast cancer.
Study: Redefining the criteria for ALK positive lung cancer
September 10, 2013 · Comments Off
A University of Colorado Cancer Center study published today in the journal Cancer shows that the current criteria used to match lung cancers with the drug crizotinib may miss some patients who could benefit from the drug.
Summer fellows wrap up a summer of cancer research
August 13, 2013 · Comments Off
Students ranging in age from high school to medical school were busy this summer in...
NTRK1: a new oncogene and target in lung cancer
August 13, 2013
alk drug lung cancer amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno biomarkers bladder cancer breast cancer cancer grants cancer research colorado Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma metastasis microRNA Monique Spillman Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge screening skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
If you were planning to attend either our brain tumor support group at University of Colorado Hospital or our... http://t.co/Wsbl49jxag
New Cancer Center study shows active component of grape seed extract effective against cancer cells. http://t.co/nq2Cfar6an
C3 Magazine: Collaborating to Conquer Cancer Fall edition is here. Read stories about fingerprinting cancer, a... http://t.co/ce9xjCSHBi
Colorado Gives Day is coming December 10! This is a great opportunity to give back to Colorado's non-profits... http://t.co/6fVKIftFal
Join the discussion Wednesday night! http://t.co/QNqnxp8n24